Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lang

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|June 25, 2025
Differential Diagnosis of Chronic Spontaneous UrticariaDimitra Gialama, Hanna Bonnekoh, Nikolai Dario Rothermel, et al.
The Journal of Allergy and Clinical Immunology|December 8, 2022
Do regional geography and race influence management of chronic spontaneous urticaria?Giselle S Mosnaim, Matthew Greenhawt, Polina Imas, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 2, 2016
Anti-Inflammatory Effects and Prediction of Blood Pressure Response by Baseline Inflammatory State in Catheter-Based Renal DenervationDavid Lang, Alexander Nahler, Thomas Lambert, et al.
Cancers|January 11, 2022
Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy-A Retrospective Bi-Centric Cohort StudyDavid Lang, Anna Brauner, Florian Huemer, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Early serum tumor marker dynamics predict progression-free and overall survival in single PD-1/PD-L1 inhibitor treated advanced NSCLC-A retrospective cohort studyDavid Lang, Andreas Horner, Elmar Brehm, et al.
Cancers|December 10, 2021
First-Line Pembrolizumab Mono- or Combination Therapy of Non-Small Cell Lung Cancer: Baseline Metabolic Biomarkers Predict OutcomesDavid Lang, Linda Ritzberger, Vanessa Rambousek, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 7, 2025
Management and Prevention of Hypersensitivity Reactions to Radiocontrast Media: A Consensus Statement From the American College of Radiology and the AAAAICarolyn Wang, Allison Ramsey, David Lang, et al.
Radiology|May 6, 2025
Management and Prevention of Hypersensitivity Reactions to Radiocontrast Media: A Consensus Statement from the American College of Radiology and the American Academy of Allergy, Asthma & ImmunologyCarolyn Wang, Allison Ramsey, David Lang, et al.
Journal of Clinical Medicine|July 13, 2019
Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 BlockadeFlorian Huemer, David Lang, Theresa Westphal, et al.
The Journal of Allergy and Clinical Immunology|January 22, 2008
Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costsCheryl S Hankin, Linda Cox, David Lang, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
The Journal of Allergy and Clinical Immunology. in Practice|June 25, 2025
Differential Diagnosis of Chronic Spontaneous UrticariaDimitra Gialama, Hanna Bonnekoh, Nikolai Dario Rothermel, et al.
The Journal of Allergy and Clinical Immunology|December 8, 2022
Do regional geography and race influence management of chronic spontaneous urticaria?Giselle S Mosnaim, Matthew Greenhawt, Polina Imas, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 2, 2016
Anti-Inflammatory Effects and Prediction of Blood Pressure Response by Baseline Inflammatory State in Catheter-Based Renal DenervationDavid Lang, Alexander Nahler, Thomas Lambert, et al.
Cancers|January 11, 2022
Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy-A Retrospective Bi-Centric Cohort StudyDavid Lang, Anna Brauner, Florian Huemer, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Early serum tumor marker dynamics predict progression-free and overall survival in single PD-1/PD-L1 inhibitor treated advanced NSCLC-A retrospective cohort studyDavid Lang, Andreas Horner, Elmar Brehm, et al.
Cancers|December 10, 2021
First-Line Pembrolizumab Mono- or Combination Therapy of Non-Small Cell Lung Cancer: Baseline Metabolic Biomarkers Predict OutcomesDavid Lang, Linda Ritzberger, Vanessa Rambousek, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 7, 2025
Management and Prevention of Hypersensitivity Reactions to Radiocontrast Media: A Consensus Statement From the American College of Radiology and the AAAAICarolyn Wang, Allison Ramsey, David Lang, et al.
Radiology|May 6, 2025
Management and Prevention of Hypersensitivity Reactions to Radiocontrast Media: A Consensus Statement from the American College of Radiology and the American Academy of Allergy, Asthma & ImmunologyCarolyn Wang, Allison Ramsey, David Lang, et al.
Journal of Clinical Medicine|July 13, 2019
Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 BlockadeFlorian Huemer, David Lang, Theresa Westphal, et al.
The Journal of Allergy and Clinical Immunology|January 22, 2008
Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costsCheryl S Hankin, Linda Cox, David Lang, et al.
Pageof 9